Ophthalmic revenues, surgeries may recover once patient safety can be assured

Ophthalmic surgeries, namely cataract and refractive procedures, and revenues will recover once patient safety can be assured during the ongoing COVID-19 pandemic, several leading industry experts said during an Eyecelerator LiveStream presentation.
In the first of a series of LiveStream events hosted by Eyecelerator, four ophthalmic industry leaders discussed the necessary steps for the ophthalmic market to recover.
David Endicott, Alcon CEO; Jag Dosanjh, Allergan senior vice president, specialty therapeutics; Warren Foust, Johnson & Johnson Vision worldwide president, surgical division;